Catalyst Wire Dossier Catalyst Wire Dossier

XEN Gel Stent

· AbbVie (Allergan)
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for XEN Gel Stent, covering 2022-03-29 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma [Phase 3]

See pricing